Infection preventiondhow can we prevent transmission of community-onset methicillin-resistant Staphylococcus aureus?

被引:1
|
作者
Kao, Carol M. [1 ]
Fritz, Stephanie A. [1 ]
机构
[1] Washington Univ, Dept Pediat, Div Pediat Infect Dis, Sch Med, 660 S Euclid Ave,MSC 8116-43-10, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
Antibiotic; Colonization; Community; Decolonization; Household; Prevention; Skin infection; Staphylococcus aureus; Transmission; Vaccine; NASAL COLONIZATION; RISK-FACTORS; RECURRENT SKIN; CHILDREN; EPIDEMIOLOGY; DECOLONIZATION; HOUSEHOLDS; MUPIROCIN; CARRIAGE; ANTIBIOTICS;
D O I
10.1016/j.cmi.2024.01.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Staphylococcus aureus is a versatile organism, capable of existing as a commensal organism while also possessing pathogenic potential. The emergence of clinically and genetically distinct strains of methicillin-resistant S. aureus (MRSA), termed community-onset MRSA (CO-MRSA), resulted in an epidemic of invasive and skin and soft tissue infections (SSTI) in otherwise healthy individuals without traditional risk factors. Colonization with S. aureus is a risk factor for developing infection and also a source of transmission to close contacts. Outbreaks of S. aureus SSTI have been described in crowded settings and within households. Thus, preventive strategies are essential to interrupt recurrent infections. Objectives: The objective of this narrative review is to provide a comprehensive, evidence-based approach to prevent transmission of CO-MRSA. We highlight key clinical trials that emphasize the importance of household and environmental S. aureus colonization in propagating household transmission. Finally, we highlight research priorities to prevent S. aureus infection. Sources: We cite primary literature from peer-reviewed publications as sources for this review. Content: Our recommended approach to the management of individuals presenting with skin abscesses includes optimal treatment of the initial infection and hygiene education. Decolonization measures should be recommended for individuals with recurrent SSTIs or whose household members have SSTIs. Targeted decolonization with topical antimicrobials should be prescribed to all affected individuals within the household. Implications: S. aureus infections result in substantial mortality and morbidity because of the high incidence of recurrent skin infections. Although current decolonization strategies are beneficial, interventions are often costly to families and effectiveness wanes over time. Results from a recently completed trial evaluating integrated periodic decolonization and household environmental hygiene will further add to our understanding of what constitutes a sustainable decolonization approach. In addition, novel preventive strategies are being developed such as S. aureus vaccines, lytic agents, probiotics, microbiota transplants, and phage therapy. Carol M. Kao, Clin Microbiol Infect 2025;31:166 (c) 2024 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:166 / 172
页数:7
相关论文
共 50 条
  • [11] An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska
    Baggett, HC
    Hennessy, TW
    Leman, R
    Hamlin, C
    Bruden, D
    Reasonover, A
    Martinez, P
    Butler, JC
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (06): : 397 - 402
  • [12] Community-onset and nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus in Spanish hospitals
    Millan, Antonio B.
    Angeles Dominguez, Maria
    Borraz, Carmen
    Pau Gonzalez, M.
    Almirante, Benito
    Cercenado, Emilia
    Padilla, Belen
    Pujol, Miguel
    Rodriguez-Bano, Jesus
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2010, 28 (06): : 336 - 341
  • [13] Methicillin-resistant Staphylococcus aureus:: risk factors associated with community-onset infections in Denmark
    Bocher, S.
    Gervelmeyer, A.
    Monnet, D. L.
    Molbak, K.
    Skov, R. L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (10) : 942 - 948
  • [14] COMMUNITY-ONSET METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN BELGIUM : CHANGING EPIDEMIOLOGY AND CLONE DIVERSIFICATION
    Brauner, J.
    Deplano, A.
    Nonhoff, C.
    De Mendonca, R.
    De Ryck, R.
    Rottiers, S.
    Denis, O.
    Struelens, M. J.
    ACTA CLINICA BELGICA, 2010, 65 (03): : 217 - 217
  • [15] Community-onset invasive methicillin-resistant Staphylococcus aureus infections following hospital discharge
    Duffy, Jonathan
    Dumyati, Ghinwa
    Bulens, Sandra
    Namburi, Swathi
    Gellert, Anita
    Fridkin, Scott K.
    Lessa, Fernanda C.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (09) : 782 - 786
  • [16] Descriptive analysis of patients with community-onset and hospital-onset methicillin-resistant Staphylococcus aureus infections
    Rosario-Rosado, RV
    René, AA
    Jones, B
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (02): : 171 - 173
  • [17] Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia
    Wooten, D. A.
    Winston, L. G.
    RESPIRATORY MEDICINE, 2013, 107 (08) : 1266 - 1270
  • [18] Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting
    Wilmer, A.
    Lloyd-Smith, E.
    Romney, M. G.
    Champagne, S.
    Wong, T.
    Zhang, W.
    Stenstrom, R.
    Hull, M. W.
    EPIDEMIOLOGY AND INFECTION, 2014, 142 (03): : 463 - 467
  • [19] Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case–control study
    M. C. Wehrhahn
    J. O. Robinson
    J. C. Pearson
    F. G. O’Brien
    H. L. Tan
    G. W. Coombs
    E. M. Pascoe
    R. Lee
    P. Salvaris
    R. Salvaris
    D. New
    R. J. Murray
    European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 1025 - 1033
  • [20] Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
    Wertheim, HFL
    Vos, MC
    CRITICAL CARE, 2005, 9 (03): : 257 - 258